search
Back to results

Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury (AURORAS)

Primary Purpose

Healthy

Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Active acupuncture
Sham acupuncture
Euglucon 5mg
Celebrex 200mg
Sponsored by
Kyunghee University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Healthy focused on measuring volunteer, BMI(25 kg/m2)

Eligibility Criteria

25 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • healthy volunteer age 25 to 40 years
  • non-smoker

Exclusion Criteria:

  • hypertension (>140/90 mmHg), diabetes any cardiovascular disease kidney disease thyroid disease cerebrovascular disease liver disease (bilirubin level >2 mg/dl) pregnancy body mass index >25 kg/m2

Sites / Locations

  • Kyung Hee University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Sham Comparator

Experimental

Experimental

Arm Label

active acupuncture

Sham acupuncture

Euglycon

Celebrex

Arm Description

The participants in this group receive real acupuncture treatment at first. Afterwards crossover study is scheduled to be performed.

The participants in this group receive sham acupuncture treatment at first. afterwards crossover study is scheduled to be performed

Glibenclamide (Euglucon, Roche Pharma) is administered 3 hours before FMD measurement.

Celebrex(celecoxib, pfizer) 200mg twice daily is administered for 5 days before FMD measurement.

Outcomes

Primary Outcome Measures

The difference of endothelial function
Endothelial function is measured by brachial flow mediated dilation (FMD). Is there a difference of forearm FMD achieved following ischemia reperfusion injury between acupuncture and control group

Secondary Outcome Measures

The difference of endothelial function
Endothelial function is also measured by brachial flow mediated dilation (FMD). Is the difference of endothelial function mediated by acupuncture hampered by Triphosphate-Sensitive Potassium (KATP) Channels inhibitor glibenclamide or selective cox-2 inhibitor celebrex if acupuncture could improve flow mediated dilation after ischemia reperfusion injury? It is performed for knowing which mechanisms are involved in this improvement if acupuncture could improve flow mediated dilation after ischemia reperfusion injury?

Full Information

First Posted
September 5, 2014
Last Updated
September 29, 2014
Sponsor
Kyunghee University Medical Center
Collaborators
Ministry of Health & Welfare, Korea
search

1. Study Identification

Unique Protocol Identification Number
NCT02255006
Brief Title
Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury
Acronym
AURORAS
Official Title
Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury Via Adenosine Triphosphate-sensitive Potassium Channels or Prostaglandin Pathway
Study Type
Interventional

2. Study Status

Record Verification Date
May 2014
Overall Recruitment Status
Unknown status
Study Start Date
May 2014 (undefined)
Primary Completion Date
October 2014 (Anticipated)
Study Completion Date
December 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kyunghee University Medical Center
Collaborators
Ministry of Health & Welfare, Korea

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Some studies suggest that acupuncture improve flow mediated dilation (FMD) that represents endothelial function, but no study has investigated whether acupuncture protects against ischemia and reperfusion (IR)-induced endothelial dysfunction in humans. This is a prospective crossover study clinical trial. In the first crossover study, 20 healthy nonsmoking volunteers (25 to 40 years old) will be randomly assigned to acupuncture or control. Endothelium-dependent, FMD of the brachial artery will be measured before and after IR (15 minutes of ischemia at the level of the proximal upper arm followed by 15 minutes of reperfusion). Acupuncture will be performed from 10 minute after ischemia till the end time of reperfusion for 20 minutes. In the second single arm study, 16 volunteers are administered oral 5mg glibenclamide two hours before IR injury (n=8) or selective cox-2 inhibitor celecoxib 200mg twice a day for 5 days to know what mechanism is responsible for acupuncture effect on IR injury. FMD measurements and acupuncture intervention during IR injury are same as above mentioned.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy
Keywords
volunteer, BMI(25 kg/m2)

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
36 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
active acupuncture
Arm Type
Experimental
Arm Description
The participants in this group receive real acupuncture treatment at first. Afterwards crossover study is scheduled to be performed.
Arm Title
Sham acupuncture
Arm Type
Sham Comparator
Arm Description
The participants in this group receive sham acupuncture treatment at first. afterwards crossover study is scheduled to be performed
Arm Title
Euglycon
Arm Type
Experimental
Arm Description
Glibenclamide (Euglucon, Roche Pharma) is administered 3 hours before FMD measurement.
Arm Title
Celebrex
Arm Type
Experimental
Arm Description
Celebrex(celecoxib, pfizer) 200mg twice daily is administered for 5 days before FMD measurement.
Intervention Type
Device
Intervention Name(s)
Active acupuncture
Intervention Description
Active acupuncture treatment group receive electroacupuncture (EA). For EA treatment, unilateral acupuncture meridian point Pericardium5 (PC5), Pericardium6 (PC6), Stomach36 (ST36), and Stomach37 (ST37) are chosen. Disposable, sterile needles and low frequency electrical stimulator (ES-160, ITO, Japan) are used. Each needle is inserted to the depth of 2cm with a 90 degree angle. Thereafter, needles are connected with the pole and electrical stimulation is applied with 2 Hertz continuous wave current. After FMD measurement, a pneumatic cuff placed above the upper arms is inflated to 200 mmHg for 15 minutes. The cuff is then deflated, and 15 minutes of reperfusion is allowed before FMD measurement again. Acupuncture is performed from after ten minutes of ischemia till end time of reperfusion
Intervention Type
Device
Intervention Name(s)
Sham acupuncture
Intervention Description
For sham intervention, nonacupuncture points are used. Electrical acupuncture is connected but electrical stimulation is not given to sham acupuncture group. Volunteers undergo FMD measurement and acupuncture like above methods.
Intervention Type
Drug
Intervention Name(s)
Euglucon 5mg
Other Intervention Name(s)
Glibenclamide
Intervention Description
8 healthy volunteers are administered 5 mg of glibenclamide (Euglucon, Roche Pharma) 3 hour before FMD measurement. This dosage has previously been shown to be able to completely inhibit forearm KATP channels. With the glibenclamide administration, a 10% dextrose infusion is started and titrated to maintain blood sugar levels between 80 and 120 mg/dL throughout the study period. 3 hours after glibenclamide administration, the subjects undergo FMD measurement before and after ischemia reperfusion injury. During ischemia reperfusion period, active acupuncture treatment is performed for 20 minutes like above method.
Intervention Type
Drug
Intervention Name(s)
Celebrex 200mg
Other Intervention Name(s)
Celecoxib
Intervention Description
8 healthy volunteers are administered celecoxib, a selective COX-2 inhibitor, 200 mg twice daily for 5 days. Last dose of celecoxib is administered at morning. Volunteers undergo FMD measurements before and after ischemia reperfusion injury in that morning of last dose of celecoxib. During ischemia reperfusion period, active acupuncture treatment is performed for 20 minutes like above method
Primary Outcome Measure Information:
Title
The difference of endothelial function
Description
Endothelial function is measured by brachial flow mediated dilation (FMD). Is there a difference of forearm FMD achieved following ischemia reperfusion injury between acupuncture and control group
Time Frame
4 week
Secondary Outcome Measure Information:
Title
The difference of endothelial function
Description
Endothelial function is also measured by brachial flow mediated dilation (FMD). Is the difference of endothelial function mediated by acupuncture hampered by Triphosphate-Sensitive Potassium (KATP) Channels inhibitor glibenclamide or selective cox-2 inhibitor celebrex if acupuncture could improve flow mediated dilation after ischemia reperfusion injury? It is performed for knowing which mechanisms are involved in this improvement if acupuncture could improve flow mediated dilation after ischemia reperfusion injury?
Time Frame
4 week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: healthy volunteer age 25 to 40 years non-smoker Exclusion Criteria: hypertension (>140/90 mmHg), diabetes any cardiovascular disease kidney disease thyroid disease cerebrovascular disease liver disease (bilirubin level >2 mg/dl) pregnancy body mass index >25 kg/m2
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Weon Kim, Professor
Phone
82-2-958-8176
Email
mylovekw@hanmail.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Weon Kim
Organizational Affiliation
Kyunghee University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kyung Hee University Medical Center
City
Seoul
ZIP/Postal Code
130-701
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Weon Kim, Professor
Phone
82-2-958-8176
Email
mylovekw@hanmail.net

12. IPD Sharing Statement

Learn more about this trial

Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury

We'll reach out to this number within 24 hrs